Use of an inhibition enzyme-linked immunosorbent assay for quantification of capsular polysaccharide or proteins in vaccines

Clinical and Vaccine Immunology

Volumn 14, Issue 3, 2007, Pages 323-327

  Inzana, Thomas J ^a   Champion, Anna ^a  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; BACTERIAL VACCINE; CYTOTOXIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; POLYSACCHARIDE VACCINE;

ACTINOBACILLUS PLEUROPNEUMONIAE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DILUTION CURVE; DRUG DETERMINATION; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOREACTIVITY; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEROTYPE;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; BACTERIAL PROTEINS; BACTERIAL VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; RABBITS;

EID: 34147158268     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00302-06     Document Type: Article

References (29)

1. Altman, E., J.-R. Brisson, and M. B. Perry. 1988. Structural studies of the capsular polysaccharide from Actinobacillus (Haemophilus) pleuropneumoniae serotype 4. Biochem. Cell Biol. 66:998-1004.
2. Anderson, P. 1978. Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type b. J. Immunol. 120:866-870.
3. Blackall, P. J., H. L. Klaasen, H. van den Bosch, P. Kuhnert, and J. Frey. 2002. Proposal of a new serovar of Actinobacillus pleuropneumoniae: serovar 15. Vet. Microbiol. 84:47-52.
4. Devenish, J., S. Rosendal, and J. T. Bossé. 1990. Humoral antibody response and protective immunity in swine following immunization with the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae. Infect. Immun. 58:3829-3832.
5. Frey, J. 1994. RTX-toxins in Actinobacillus pleuropneumoniae and their potential role in virulence, p. 325-340. In C. I. Kado and J. H. Crosa (ed.), Molecular mechanisms of bacterial virulence. Kluwer Academic Publishers, Amsterdam, The Netherlands.
6. Frey, J. 1995. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends Microbiol. 3:257-261.
7. Harlow, E., and D. Lane. 1988. Antibodies: a Laboratory manual, p. 553-612. Cold Spring Harbor, New York, NY.
8. Inzana, T. J. 1987. Purification and partial characterization of the capsular polymer of Haemophilus pleuropneumoniae serotype 5. Infect. Immun. 55:1573-1579.
9. Inzana, T. J. 1995. Simplified procedure for preparation of sensitized latex particles to detect capsular polysaccharides: application to typing and diagnosis of Actinobacillus pleuropneumoniae. J. Clin. Microbiol. 33:2297-2303.
10. Inzana, T. J. 1991. Virulence properties of Actinobacillus pleuropneumoniae. Microb. Pathog. 11:305-316.
11. Inzana, T. J., G. F. Clark, and J. Todd. 1990. Detection of serotype-specific antibodies or capsular antigen of Actinobacillus pleuropneumoniae by a double-label radioimmunoassay. J. Clin. Microbiol. 28:312-318.
12. Inzana, T. J., and B. Fenwick. 2001. Serologic detection of Actinobacillus pleuropneumoniae in swine by capsular polysaccharide- biotin-streptavidin enzyme-linked immunosorbent assay. J. Clin. Microbiol. 39:1279-1282.
13. Inzana, T. J., B. Iritani, R. P. Gogolewski, S. A. Kania, and L. B. Corbeil. 1988. Purification and characterization of lipooligosaccharides from four strains of "Haemophilus somnus." Infect. Immun. 56:2830-2837.
14. Inzana, T. J., and B. Mathison. 1987. Serotype specificity and immunogenicity of the capsular polymer of Haemophilus pleuropneumoniae serotype 5. Infect. Immun. 55:1580-1587.
15. Inzana, T. J., J. Todd, J. N. Ma, and H. Veit. 1991. Characterization of a non-hemolytic mutant of Actinobacillus pleuropneumoniae serotype 5: role of the 110 kilodalton hemolysin in virulence and immunoprotection. Microb. Pathog. 10:281-296.
16. Inzana, T. J., J. Todd, and H. P. Veit. 1993. Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines. Infect. Immun. 61:1682-1686.
17. Kamp, E. M., J. K. Popma, J. Annkotta, and M. A. Smits. 1991. Identification of hemolytic and cytotoxic proteins of Actinobacillus pleuropneumoniae by use of monoclonal antibodies. Infect. Immun. 59:3079-3085.
18. Kamp, E. M., and L. A. M. G. van Leengoed. 1989. Serotype-related differences in production and type of heat-labile hemolysin and heat-labile cytotoxin of Actinobacillus (Haemophilus) pleuropneumoniae. J. Clin. Microbiol. 27:1187-1191.
19. Ma, J., and T. J. Inzana. 1990. Indirect enzyme-linked immunosorbent assay for detection of antibody to a 110,000-molecular-weight hemolysin of Actinobacillus pleuropneumoniae. J. Clin. Microbiol. 28:1356-1361.
20. Ma, J., and T. J. Inzana. 1992. Rapid purification of a 110-kilodalton hemolysin of Actinobacillus pleuropneumoniae by monoclonal antibody-affinity chromatography. Am. J. Vet. Res. 53:59-62.
21. Martin, P. G., P. Lachance, and D. F. Niven. 1985. Production of RNA-dependent haemolysin by Haemophilus pleuropneumoniae. Can. J. Microbiol. 31:456-462.
22. Nielsen, R. 1979. Haemophilus parahaemolyticus serotypes - pathogenicity and cross immunity. Nord. Vet. Med. 31:407-413.
23. Nielsen, R. 1984. Haemophilus pleuropneumoniae serotypes - cross protection experiments. Nord. Vet. Med. 36:221-234.
24. Odeyale, C. O., and Y. H. Kang. 1988. Biotinylation of bacterial lipopolysaccharide and its applications to electron microscopy. J. Histochem. Cytochem. 36:1131-1137.
25. Perry, M. B., E. Airman, J.-R. Brisson, L. M. Beynon, and J. C. Richards. 1990. Structural characteristics of the antigenic capsular polysaccharides and lipopolysaccharides involved in the serological classification of Actinobacillus (Haemophilus) pleuropneumoniae strains. Serodiagn. Immunother. 4:299-308.
26. Reimer, D., J. Frey, R. Jansen, H. P. Veit, and T. J. Inzana. 1995. Molecular investigation of the role of ApxI and ApxII in the virulence of Actinobacillus pleuropneumoniae serotype 5. Microb. Pathog. 18:197-209.
27. Rosendal, S., J. Devenish, J. I. Machines, J. H. Lumsden, S. Watson, and H. Xun. 1988. Evaluation of heat-sensitive, neutrophil-toxic, and hemolytic activity of Haemophilus (Actinobacillus) pleuropneumoniae. Am. J. Vet. Res. 49:1053-1058.
28. Schaller, A., R. Knhn, P. Kuhnert, J. Nicolet, T. J. Anderson, J. I. MacInnes, R. P. Segers, and J. Frey. 1999. Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae. Microbiology (Reading, England) 145:2105-2116.
29. Wyle, F. A., M. S. Artenstein, B. L. Brandt, E. C. Tramont, D. L. Kasper, P. L. Altieri, S. L. Berman, and J. P. Lowenthal. 1972. Immunologic response of man to group B meningococcal polysaccharide vaccines. J. Infect. Dis. 126:514-521.